Kana Lessig Stemsoft Software May 2026

(e.g., a case study or press release).

STEMSOFT provides the industry's leading cellular therapy software solutions, designed specifically to manage this complexity. By offering comprehensive informatics solutions that focus on end-to-end information management, we empower providers to:

Manufacturing and administering advanced therapies requires complete, accurate, and detailed records. Whether you are a cord blood bank, a public marrow transplant center, or a commercial cell therapy manufacturer, the regulatory landscape is constantly evolving, requiring strict adherence to FACT/JACIE, AABB, cGMP, and cGTP standards. Kana Lessig Stemsoft Software

Manually tracking these data points—from collection to apheresis, manufacturing, and final infusion—leads to inefficiencies and potential risks. Streamlining Compliance with Configurable Informatics

Data aggregation is only the first step. True success lies in data mining. STEMSOFT platforms, including StemLab™ and BMTserve™, allow laboratories to generate actionable insights and visualizations on the fly—without needing to be a report-writing expert. Whether you are a cord blood bank, a

Blog Post: The Future of Cell Therapy Informatics: Ensuring Compliance in an Accelerating Field Date: April 28, 2026

all of their CAR-T, IEC, and research work. Ensure compliance with 21 CFR Part 11, HIPAA, and GDPR. True success lies in data mining

However, STEMSOFT is a leader in cell therapy informatics. Here is a blog post tailored to their specialized work.